Companies: 10,795·Total market cap: $144.5T
NeutriSci International Inc.

NeutriSci International Inc.

NRXCFOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$653980
P/E Ratio
52W High$0.0013
52W Low$0.0013
Overview

NeutriSci International Inc. (NRXCF) Revenue

Annual & quarterly revenue history · segment & region breakdown

NRXCF · revenue · updated Jun 9, 2026

Core revenue metrics

NeutriSci International Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
10.90×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
0 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · NeutriSci International Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
NRXCF revenue by year · NRXCF revenue history · NRXCF annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income NeutriSci International Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

NeutriSci International Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from NeutriSci International Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

NRXCF revenue · 4 questions

NRXCF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

NRXCF revenueNRXCF annual revenuewhat is NRXCF revenueNRXCF TTM revenue

Source: FMP · NeutriSci International Inc. SEC filings · GAAP · NeutriSci International Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026